![Keith B. Hoffman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith B. Hoffman
Direttore operativo presso Thuris Corp.
Posizioni attive di Keith B. Hoffman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Thuris Corp.
![]() Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA. | Direttore operativo | - | - |
Proteas Bioanalytics, Inc.
![]() Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Keith B. Hoffman
Precedenti posizioni note di Keith B. Hoffman
Società | Posizione | Inizio | Fine |
---|---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Ancile Pharmaceuticals, Inc.
![]() Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Corporate Officer/Principal | - | - |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | 30/12/2009 | - |
Formazione di Keith B. Hoffman
University of California, Irvine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
Aziende private | 4 |
---|---|
Thuris Corp.
![]() Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA. | Health Technology |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
Ancile Pharmaceuticals, Inc.
![]() Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Health Technology |
Proteas Bioanalytics, Inc.
![]() Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Technology Services |
- Borsa valori
- Insiders
- Keith B. Hoffman
- Esperienza